Copyright © 2008 ScoutNews LLC. All rights reserved. MONDAY, March 31 (HealthDay News) — The diabetes drug Actos is better than another diabetes drug, Amaryl, at slowing clogging of the arteries in patients with both type 2 diabetes and cardiovascular disease.

Read More

A study published in JAMA reports that the drugpioglitazone is more effective at reducing the rate of plaque build-upin the coronary arteries than the drug glimepiride. Both medicationsare designed to treat type 2 diabetes (also known as adult-onsetdiabetes).

Read More

Type 1 juvenile diabetes occurs when the infiltration of activated T lymphocytes and monocytes into the islets of Langerhans of the pancreas causes the immune system to destroy insulin-producing beta cells.

Read More

The Auckland scientist who pioneered pig-cell transplants to treat type 1 diabetes has threatened to give up plans for a trial at Middlemore Hospital if the Government continues to delay its regulatory approval.

Read More

New data from a clinical trial using intravascular ultrasound (IVUS) technology found that in patients living with type 2 diabetes, ACTOS (pioglitazone HCl) reduced the atherosclerotic burden in the coronary arteries compared to glimepiride, and prevented progression compared to baseline. These data stem from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary …

Read More

A new glucose-lowering drug used in diabetics also cuts the build-up of plaque in the arteries, say researchers. A reduction in atherosclerosis or the ‘furring up’ of the arteries could lower the risk of heart attacks, which are more likely to be fatal in patients with diabetes

Read More

A comparison of two types of medications to treat type 2 diabetes finds that pioglitazone is more effective at lowering the rate of progression of plaque build-up in the coronary arteries than glimepiride, according to a study in the April 2 issue of JAMA. This study is being released early online March 31 to coincide with its presentation at the annual conference of the American College of …

Read More

MONDAY, March 31 (HealthDay News) — The diabetes drug Actos is better than another diabetes drug, Amaryl, at slowing clogging of the arteries in patients with both type 2 diabetes and cardiovascular disease.

Read More

Researchers have uncovered new genetic clues for diabetes and cancer of the colon and rectum, according to papers published on Sunday in the journal Nature Genetics.

Read More

U.S. and European scientists have found six more genes that make people more susceptible to developing type 2 diabetes, in a study they say may help prevent and treat the chronic condition.

Read More